Bergen, Norway 1 December 2022
Lifecare AS will present Q3 2022 financial and operational status in a webcastTuesday 6 December. For more information of the webcast and other news, read Lifecare's latestnewsletter: https://lifecare.attme.dev/news/information-from-lifecare-november-2022/
This is Lifecare: Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people with diabetes. The Company's patented technology also has thepotential for use in various biomarkers. Lifecare AS is listed on EuronextGrowth (LIFE).
Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.attme.dev,+47 40 05 90 40
This stock exchange announcement was published by Joacim Holter, CEO at LifecareAS, on 1.12.22 at 09:58 CET.